TrialSaudi medical journal2022

Effect of a low dose of empagliflozin on short-term outcomes in type 2 diabetics with acute coronary syndrome after percutaneous coronary intervention.

Seyed Mohammad H Adel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.